C4A and myeloid sarcoma: However, recent data indicate that specific clones of B cells (e.g., IgM-producing B1 B cells) and certain complement subunits (e.g., C4) also play neuroprotective roles and could be used in the future therapy of many types of neurologic disorders, including TBI, MS, AD, and epilepsy.